Rasburicase belongs to the class of endocrine drugs. It is an enzyme converting uric acid to allantoin for the purpose of treating hyperuricemia with malignancy.
Rasburicase is only available as intravenous injections in Hong Kong with no filter and as an infusion, but not bolus. Your doctor will advise you on the dosage and frequency depending on the risk of your hyperuricemia.
Hyperuricemia associated with malignancy
Infant, Child, Adolescent, Adult and Elderly
0.05-0.2 mg/kg once daily for 1-7 days.
Common dosing schedule:
Rasburicase is to be injected once daily through the veins by healthcare professionals.
This schedule is for reference only, adjustments may be made according to individual needs.
Some common medications Rasburicase may interact with:
Please notify your doctor or pharmacist if you are taking the above medication, dosage adjustments might be needed.
In Hong Kong, Rasburicase is a prescription only medicine, and requires a prescription from a doctor to be purchased in a pharmacy. It can also be obtained from doctors. To find a pharmacy near you, refer to the list of pharmacies (“Authorized Sellers of Poisons”) from the Hong Kong Department of Health.
For more information about drug names and ingredients, you can visit Hong Kong’s Drug Office at https://www.drugoffice.gov.hk
Need more information?
For detailed information about the use of Rasburicase in children, pregnancy and breastfeeding, and for questions about drug interactions, please check with your pharmacist or doctor.
Disclaimer: our goal is to provide you with the most relevant drug information and common dosage for Hong Kong. This information does not constitute medical advice. For specific treatment recommendations and advice, always discuss with your doctor or pharmacist, and follow the instructions included with your specific medicine.